Translating a screening questionnaire for spondyloarthritis in people with bowel disease
Checks French versions of two joint inflammation questionnaires for adults with bowel disease.
Plain-language title generated from the registry record
Registry title: Spondylo-arthritis Screening Tool Among Patient Suffering From Inflammatory Bowel Disease
Key facts
- Where
- Grenoble, FranceSee the site
Where in France
- university Hospital GrenobleGrenoble, FranceNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Grenoble
- Trial code
- NCT06998316
- Record updated
- 31 May 2025
- Original description
The QUESAM study aims to translate into French and validate the traduction of 2 screening questionnaires for spondylo-arthritis among people with inflammatory bowel disease.Read full original descriptionShow less
Linguistical Validation of a Spondylo-arthritis Screening Tool for Patients Suffering From Inflammatory Bowel Disease
The QUESAM study aims to translate into French and validate the traduction of 2 screening questionnaires for spondylo-arthritis among people with inflammatory bowel disease.
DETAIL (DETection of Arthritis in Inflammatory boweL diseases) and IBIS-Q (Inflammatory Bowel disease Identification of Spondyloarthritis Questionnaire) questionnaires are built to determine which patients might benefit from a rheumatologic consultation, for a potential rheumatologic inflammatory disease.
The investigators will translate the 2 questionnaire in french thanks to an external translation company, from english to french, then back to english to make sure the translation is correct.
Then, the main question is:
is there a conceptual and semantic equivalence beetween the original english questionnaire and the french-translated one.
Participant will answer the 2 screening questionnaire, one initial time during a consultation, and a second time after 1 month.
Inclusion: Patient with an inflammatory bowel disease according to gastroenterologist.
Exclusion: No exclusion criteria; Difficulty for understanding or reading french; Persons covered by articles L1121-5 to L1121-8 of the French Public Health Code; Patients with no social security coverage; Patients refusing to participate voluntarily.